Jingjing Li

Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap

Wantong Song, Limei Shen, Ying Wang et al. · Nature Communications · 2018 · 404 citations · Full text

Medicine, Oncology, Pharmacology +17

Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade

Jun Zhou, Kathleen M. Mahoney, Anita Giobbie‐Hurder et al. · Cancer Immunology Research · 2017 · 362 citations · Full text

Life Sciences, Immunology, Oncology +17

Statins Induce the Accumulation of Regulatory T Cells in Atherosclerotic Plaque

Xiao Meng, Kai Zhang, Jingjing Li et al. · Molecular Medicine · 2012 · 110 citations · Full text

Medicine, Cardiology, Immunology +16

Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN

Yunmeng Zhang, Yuting Ji, Siwen Liu et al. · Journal of the National Cancer Center · 2025 · 107 citations · Full text

Medicine, Oncology, Population Health Sciences +17

Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022

Jie Wu, Qianyun Jin, Yunmeng Zhang et al. · Journal of the National Cancer Center · 2025 · 95 citations · Full text

Medicine, Oncology, Population Health Sciences +17